A Phase 1 Clinical Trial of ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension (PAH)
Phase of Trial: Phase I
Latest Information Update: 02 May 2018
At a glance
- Drugs Sirolimus (Primary)
- Indications Pulmonary arterial hypertension
- Focus Adverse reactions
- Sponsors AADi
- 19 Jul 2017 Status changed from not yet recruiting to recruiting.
- 21 Jul 2016 Planned primary completion date changed from 1 Feb 2019 to 1 Aug 2019.
- 21 Jul 2016 Planned initiation date changed from 1 Feb 2016 to 1 Aug 2016.